Pharmacotherapy : a pathophysiologic approach

著者

• DiPiro, Joseph T.

書誌事項

Pharmacotherapy : a pathophysiologic approach

Joseph T. DiPiro ... [et al.]

McGraw-Hill Education, c2017

10th ed

統一タイトル

Pharmacotherapy (New York)

注記

Includes bibliographical references and index

内容説明・目次

内容説明

The landmark text on how to achieve optimal patient outcomes through evidence-based medication therapy Pharmacotherapy: A Pathophysiologic Approach is written to help readers advance the quality of patient care through evidence-based medication therapy derived from sound pharmacotherapeutic principles. The scope of this trusted classic goes beyond drug indications and dosages to include the initial selection, proper administration, and monitoring of drugs. Readers will find everything they need to provide safe, effective drug therapy across the full range of therapeutic categories. This edition is enriched by more than 300 expert contributors, and every chapter has been revised and updated to reflect the latest in evidence-based information and recommendations. Important features such as Key Concepts at the beginning of each chapter, Clinical Presentation tables that summarize disease signs and symptoms, and Clinical Controversies boxes that examine the complicated issues faced by students and clinicians in providing drug therapy make this text an essential learning tool for students, patient-focused pharmacists, and other health care providers. * A section on personalized pharmacotherapy appears in most sections * All diagnostic flow diagrams, treatment algorithms, dosing guideline recommendations, and monitoring approaches are in full color to clearly distinguish treatment pathways * New drug monitoring tables have been added * Most of the disease-oriented chapters have incorporated evidence-based treatment guidelines that when available, include ratings of the level of evidence to support the key therapeutic approaches * Twenty-four online-only chapters are available at www.pharmacotherapyonline.com

目次

Contributors Foreword Foreword to the First Edition Preface Section 1 Foundation Issues e1. Health Literacy and Medication Use e2. Cultural Competency e3. Medication Safety Principles and Practices e4. Clinical Pharmacokinetics and Pharmacodynamics e5. Pharmacogenetics e6. Pediatrics e7. Geriatrics e8. Palliative Care e9. Clinical Toxicology e10. Clinical Management of Potential Bioterrorism-related Conditions Section 2 Cardiovascular Disorders e11. Cardiovascular Testing 12. Cardiac Arrest 13. Hypertension 14. Chronic Heart Failure 15. Acute Decompensated Heart Failure 16. Stable Ischemic Heart Disease 17. Acute Coronary Syndromes 18. The Arrhythmias 19. Venous Thromboembolism 20. Stroke 21. Dyslipidemia e22. Peripheral Arterial Disease 23. Use of Vasopressors and Inotropes in the Pharmacotherapy of Shock 24. Hypovolemic Shock e25. Introduction to Pulmonary Function Testing Section 3 Respiratory Disorders 26. Asthma 27. Chronic Obstructive Pulmonary Disease 28. Pulmonary Arterial Hypertension 29. Cystic Fibrosis e30. Drug-Induced Pulmonary Diseases Section 4 Gastrointestinal Disorders e31. Evaluation of the Gastrointestinal Tract 32. Gastroesophageal Reflux Disease 33. Peptic Ulcer Disease and Related Disorders 34. Inflammatory Bowel Disease 35. Nausea and Vomiting 36. Diarrhea, Constipation, and Irritable Bowel Syndrome 37. Portal Hypertension and Cirrhosis e38. Drug-Induced Liver Disease 39. Pancreatitis 40. Viral Hepatitis 41. Celiac Disease Section 5 Renal Disorders e42. Evaluation of Kidney Function 43. Acute Kidney Injury 44. Chronic Kidney Disease 45. Hemodialysis and Peritoneal Dialysis 46. Drug-Induced Kidney Disease 47. Glomerulonephritis 48. Drug Therapy Individualization for Patients with Chronic Kidney Disease 49. Disorders of Sodium and Water Homeostasis 50. Disorders of Calcium and Phosphorus Homeostasis 51. Disorders of Potassium and Magnesium Homeostasis 52. Acid-Base Disorders Section 6 Neurologic Disorders e53. Evaluation of Neurologic Illness 54. Alzheimer Disease 55. Multiple Sclerosis 56. Epilepsy 57. Status Epilepticus 58. Acute Management of the Brain Injury Patient 59. Parkinson Disease 60. Pain Management 61. Headache Disorders Section 7 Psychiatric Disorders e62. Assessment of Psychiatric Disorders 63. Attention Deficit/Hyperactivity Disorder 64. Eating Disorders 65. Substance-Related Disorders I: Overview and Depressants, Stimulants, and Hallucinogens 66. Substance-Related Disorders II: Alcohol, Nicotine, and Caffeine 67. Schizophrenia 68. Major Depressive Disorder 69. Bipolar Disorder 70. Anxiety Disorders: Generalized Anxiety, Panic, and Social Anxiety Disorders 71. Posttraumatic Stress Disorder and Obsessive-Compulsive Disorder 72. Sleep-Wake Disorders 73. Disorders Associated with Intellectual Disabilities Section 8 Endocrinologic Disorders 74. Diabetes Mellitus 75. Thyroid Disorders 76. Adrenal Gland Disorders e77. Pituitary Gland Disorders Section 9 Gynecologic and Obstetric Disorders 78. Pregnancy and Lactation: Therapeutic Considerations 79. Contraception 80. Menstruation-Related Disorders 81. Endometriosis 82. Hormone Therapy in Women Section 10 Urologic Disorders 83. Erectile Dysfunction 84. Benign Prostatic Hyperplasia 85. Urinary Incontinence Section 11 Immunologic Disorders e86. Function and Evaluation of the Immune System 87. Systemic Lupus Erythematosus e88. Drug Allergy 89. Solid-Organ Transplantation Section 12 Rheumatologic Disorders 90. Osteoarthritis 91. Rheumatoid Arthritis 92. Osteoporosis and Osteomalacia 93. Gout and Hyperuricemia Section 13 Ophthalmic and Otolaryngological Disorders 94. Glaucoma 95. Allergic Rhinitis Section 14 Dermatologic Disorders 96. Acne Vulgaris 97. Psoriasis 98. Atopic Dermatitis e99. Dermatologic Drug Reactions and Common Skin Conditions Section 15 Hematologic Disorders 100. Anemias 101. Coagulation Disorders 102. Sickle Cell Disease e103. Drug-Induced Hematologic Disorders Section 16 Infectious Diseases e104. Laboratory Tests to Direct Antimicrobial Pharmacotherapy 105. Antimicrobial Regimen Selection 106. Central Nervous System Infections 107. Lower Respiratory Tract Infections 108. Upper Respiratory Tract Infections 109. Influenza 110. Skin and Soft-Tissue Infections 111. Infective Endocarditis 112. Tuberculosis 113. Gastrointestinal Infections and Enterotoxigenic Poisonings 114. Intra-Abdominal Infections e115. Parasitic Diseases 116. Urinary Tract Infections and Prostatitis 117. Sexually Transmitted Diseases 118. Bone and Joint Infections 119. Sepsis and Septic Shock 120. Superficial Fungal Infections 121. Invasive Fungal Infections 122. Infections in Immunocompromised Patients 123. Antimicrobial Prophylaxis in Surgery e124. Travel Health 125. Vaccines and Immunoglobulins 126. Human Immunodeficiency Virus Infection Section 17 Oncologic Disorders 127. Cancer Treatment and Chemotherapy 128. Breast Cancer 129. Lung Cancer 130. Colorectal Cancer 131. Prostate Cancer 132. Lymphomas 133. Ovarian Cancer 134. Acute Leukemias 135. Chronic Leukemias 136. Multiple Myeloma e137. Myelodysplastic Syndromes e138. Renal Cell Carcinoma 139. Melanoma 140. Hematopoietic Stem Cell Transplantation Section 18 Nutritional Disorders 141. Assessment of Nutrition Status and Nutrition Requirements 142. Parenteral Nutrition 143. Enteral Nutrition 144. Obesity Index

「Nielsen BookData」 より

詳細情報

• NII書誌ID(NCID): BB23354637
• ISBN:
  • 9781259587481
• LCCN: 2016035246
• 出版国コード: us
• タイトル言語コード: eng
• 本文言語コード: eng
• 出版地: New York
• ページ数/冊数: xxxiii, 2474p.
• 大きさ: 29cm
• 分類:
  • LCC : RM263
  • NLM : WB 330
  • DC23 : 615.5/8
• 件名:
  • MESH : Drug Therapy